Scientific Program

- Session times are Korea Standard Time (UTC/GMT+9). Please click the link and check your local time.
- Program is subject to change.
- Program will be updated continuously.
- Some sessions are in Korean.

  • Wednesday, October 18
  • Thursday, October 19
  • Friday, October 20
  • Oral Presentation
  • Education Workshop

Thursday, October 19

[SY03]
ADLM-KSLM: A Roadmap to Successful Data Analytics Projects at your Institution Today and in the Future​

Date & Time October 19 (Thu.),
09:00-10:30​
Room Room A (3F)​ Language Eng
Chair(s)
  1. Hyosoon Park, Sungkyunkwan University School of Medicine, Korea
    Hyunghoi Kim, Pusan National University School of Medicine, Korea
Speaker(s)
  1. The ABCs of Data Analytics in the Laboratory: Tackling Complexity with Confidence​
    Thomas Durant, Yale School of Medicine, USA​
  2. Practical Use of Data to Guide Decision Making in the Clinical Laboratory​
    David Peaper , Yale School of Medicine, USA​
  3. Taking Laboratory Analytics to the Next Level: Development of Purpose-Built Infrastructure and Resources to Fuel Improved Laboratory Medicine​
    Patrick Mathias , University of Washington School of Medicine, USA

[SY04]
CLSI-KSLM: Introduction of key CLSI documents​

This symposium introduces updated or essential CLSI guidelines. In this session, not only POCT05 and MM24 guidelines will be introduced, but also the CEO of CLSI will discuss CLSI's global imperatives.

Date & Time October 19 (Thu.),
09:00-10:30​
Room Room B (3F)​ Language Eng
Chair(s)
  1. Jin Kyung Lee, Korea Cancer Center Hospital, Korea
    Young Ree Kim, Jeju National University School of Medicine, Korea
Speaker(s)
  1. CLSI’s Global Imperative: Enabling Diagnostic Integrity and Innovation​
    Barb Jones, Chief Executive Officer of CLSI, USA​
  2. POCT05, Performance Metrics for Continuous Interstitial Glucose Monitoring​
    James H. Nichols, Vanderbilt University School of Medicine, USA​
  3. MM24, Molecular Methods for Genotyping and Strain Typing of Infectious Organisms​
    Hyewon Park, Seegene Medical Foundation, Korea

[SY05]
Monitoring minimal residual disease (MRD) in the age of next-generation technology

In recent years, there have been significant advancements in next-generation sequencing (NGS) and other technologies that enable highly sensitive and specific detection of minimal residual disease (MRD) in hematologic malignancy patients. Monitoring MRD is becoming increasingly important in cancer care, as it can provide important information about a patient's response to treatment and the likelihood of disease recurrence. The use of NGS and other advanced technologies for MRD monitoring is revolutionizing cancer care, enabling earlier detection of disease relapse and more personalized treatment approaches.
In this session, we will explore the latest developments in MRD monitoring using next-generation technology. We will discuss the benefits and limitations of these approaches, as well as their potential impact on hematologic malignancy. We will also examine the challenges associated with implementing these technologies in clinical practice, accessibility, and standardization.

Date & Time October 19 (Thu.),
09:00-10:30​
Room Room C (3F)​ Language Eng
Chair(s)
  1. Yong Goo Kim, The Catholic University of Korea College of Medicine, Korea
    Seongsoo Jang, University of Ulsan College of Medicine, Korea
Speaker(s)
  1. Testing for Minimal Residual Disease (MRD) in Acute Myeloid Leukemia (AML) using Next-Generation Technology​
    James L. Zehnder, Stanford University School of Medicine, USA
  2. Clinical Implications of Measurable Residual Disease (MRD) in Acute Myeloid Leukemia (AML)
    Byung Sik Cho, The Catholic University of Korea, Korea
  3. Testing for Minimal Residual Disease (MRD) in Acute Lymphoblastic Leukemia (ALL) using Next-Generation Technology​
    Miyoung Kim, Asan Medical Center, University of Ulsan College of Medicine, Korea
  4. Recent Updates on Monitoring Minimal Residual Disease (MRD) in Multiple Myeloma​
    Hyun-Young Kim, Samsung Medical Center, Sungkyunkwan University School of Medicine, Korea​

[PL02]
Plenary Lecture 02​

Date & Time October 19 (Thu.),
10:50-11:50​
Room Room A (3F)​ Language Eng
Chair(s)
  1. Sail Chun, University of Ulsan College of Medicine, Korea
Speaker(s)
  1. Unlocking the power of laboratory medicine: creating virtual biorepositories in the electronic health record​
    Octavia M. Peck Palmer, University of Pittsburgh School of Medicine, USA​

[KS01]
Keynote Speech​

Date & Time October 19 (Thu.),
13:00-13:40​
Room Room A (3F)​ Language Eng
Chair(s)
  1. Gye Cheol Kwon, Chungnam National University College of Medicine, Korea
Speaker(s)
  1. Digital healthcare and data science​
    Hee Hwang, Kakao Healthcare, Korea​

[KS02]
Keynote Speech​

Date & Time October 19 (Thu.),
13:50-14:30​
Room Room A (3F)​ Language Eng
Chair(s)
  1. Yunjung Cho, Korea University College of Medicine, Korea
Speaker(s)
  1. The CAP-Your resource for artificial intelligence information​
    Emily Volk, UofL Health – UofL Hospital, USA​

[SY06]
Ultrafast and sensitive screening of pathogens by biosensors​

This symposium introduces new technologies for faster and more sensitive detection of pathogens.

Date & Time October 19 (Thu.),
13:00-14:30​
Room Room B (3F)​​ Language Eng
Chair(s)
  1. Sunjoo Kim, Gyeongsang National University College of Medicine, Korea
    Mi-Na Kim, University of Ulsan College of Medicine, Korea
Speaker(s)
  1. Nanobiomaterials for the diagnosis and treatment of infectious diseases​
    Jonghoon Choi, College of ICT Engineering, Chung-Ang University, Korea​
  2. Quantum Dot-Based Lateral Flow Immunoassay for the Rapid Detection of Pathogens​
    Soo-Kyung Kim, Ewha Womans University College of Medicine, Korea​
  3. Accurate pathogen detection using dPCR​
    Jacob Moran-Gilad, Ben-Gurion University of the Negev, Israel​

[SY07]
Updates on diagnostics and therapeutics for lipid management of cardiovascular disease​​

The adequate management of lipids is key to ensuring good clinical outcomes of cardiovascular diseases. This symposium will discuss up-to-date guidelines regarding lipid management and diagnostic techniques regarding lipid measurement and analysis.

Date & Time October 19 (Thu.),
13:00-14:30​
Room Room C (3F)​ Language Eng
Chair(s)
  1. Je Hoon Lee, The Catholic University of Korea College of Medicine, Korea
    Yong-Wha Lee, Soonchunhyang University College of Medicine, Korea
Speaker(s)
  1. Overview of updated guidelines on lipid management of cardiovascular disease​
    Seonghoon Choi, Kangnam Sacred Heart Hospital, Hallym University College of Medicine​, Korea
  2. Quantification of lipoprotein by LC-MS/MS​
    Hubert W Vesper, Centers for Disease Control and Prevention, USA​
  3. Impacts of Lipid Analysis on Cardiovascular Disease Management​
    Sang Hoon Song, Seoul National University College of Medicine, Korea

[SY08]
Development of clinical practice guideline of cfDNA assay​

The clinical practice guideline of circulating tumor DNA (ctDNA) assay was developed by Clinical practice guideline committee of Korean Society of Laboratory Medicine. This session aims to introduce the method of development of clinical practice guideline, and the developed ctDNA assay guideline.

Date & Time October 19 (Thu.),
13:00-14:30​
Room Room D (4F)​ Language Eng
Chair(s)
  1. Yonggon Cho, Jeonbuk National University Medical School, Korea
    Eun Young Song, Seoul National University College of Medicine, Korea
Speaker(s)
  1. Development of Clinical Practice Guideline​​
    Soo Yong Kim, Hallym University College of Medicine, Korea​
  2. Pre-analytical guideline for ctDNA assay​
    Saeam Shin, Yonsei University College of Medicine, Korea​​
  3. Analytical guideline for ctDNA assay​
    Jee-Soo Lee, Seoul National University College of Medicine, Korea​
  4. Interpretation & Report for ctDNA assay​
    Eun Hye Cho, Kangbuk Samsung Hospital, Korea​

[SY09]
Current progress and challenges in genomics and genetics​

This symposium introduces various advances in genomics and genetics as well as the challenges facing them.

Date & Time October 19 (Thu.),
14:50-16:20​
Room Room B (3F)​​ Language Eng
Chair(s)
  1. Chang-Ho Jeon, Catholic University of Daegu School of Medicine, Korea
    Kyung A Lee, Yonsei University College of Medicine, Korea
Speaker(s)
  1. Three-dimensional genome organization shaped by chromatin architectural protein CTCF​
    Hyoung-Pyo Kim, Yonsei University College of Medicine, Korea​
  2. Retroelements in genomic medicine: discovery, interpretation, and therapeutic implications ​
    Eunjung (Alice) Lee , Division of Genetics and Genomics at Boston Children’s Hospital and Harvard Medical School, USA​​
  3. BRCA mutations among Korean patients​​
    Jong-Won Kim, Sungkyunkwan University School of Medicine, Korea​

[SY10]
Artificial intelligence and data quality​

As the era of artificial intelligence begins in earnest, new technologies based on AI are being used in the medical field. Data is essential for machine learning in AI, and Big data can be used to increase the accuracy of AI. However, the use of low-quality data leads to improper learning outcomes and eventually inappropriate decision-making. In this session, we will review AI recently introduced in medicine and discuss the importance of data quality and management.

Date & Time October 19 (Thu.),
14:50-16:20​
Room Room C (3F)​ Language Eng
Chair(s)
  1. Yeo-Min Yun, Konkuk University Medical Center, Korea
    Jeong Hwan Shin, Inje University College of Medicine, Korea
Speaker(s)
  1. Health Care Using Artificial Intelligence-Continuous Blood Glucose Monitoring​
    Junhwan Kim, Kakaohealtcare, Korea​
  2. The importance of data quality and validation experience in the era of AI ​
    Jong-Yeup Kim, Konyang University, Korea​
  3. Proposal for Data Quality Management in Laboratory Medicine​
    Sollip Kim, University of Ulsan College of Medicine, Korea

[SY11]
A new perspective on cord blood banks​​

To provide fresh insight into the significance of umbilical cord blood, whose value has been diminished as a result of haploidentical hematopoietic stem cell transplantation.

Date & Time October 19 (Thu.),
14:50-16:20​
Room Room D (4F)​ Language Eng
Chair(s)
  1. Tae Hyun Um, Inje University College of Medicine, Korea
    Sue Shin, Seoul National University College of Medicine, Korea
Speaker(s)
  1. Innovative Adult Stem Cell Drug using Human Umbilical Cord Blood-derived Mesenchymal Stem Cells​
    Soo Jin Choi, MEDIPOST Advanced Regenerative Medicine Research Instititute, Korea​
  2. Development of cord blood cells based Immunotherapeutics ​
    Seok-Ho Kim, Dept. of medicinal biotechnology Dong-A University, Korea​
  3. Establishment of a clinical-grade HLA haplobank of iPSCs in Japan and future perspective​
    Shinsuke Yoshida, CiRA Foundation, Japan